Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Australian Tartaric Products (ATP) is a leading manufacturer of natural tartaric acid and related grape-derived products, based in Victoria, Australia. The company specializes in the recovery and processing of winery by-products, such as grape marc and lees, to produce high-quality ingredients for the pharmaceutical, food, and beverage industries. Their product portfolio includes L(+) tartaric acid, cream of tartar, and grape spirit, all produced using sustainable extraction methods. ATP serves as a critical supplier to the global healthcare sector, providing pharmaceutical-grade excipients used in the formulation of effervescent tablets and other medicinal products. As part of the Italy-based Mazzari Group, the company leverages extensive expertise in viticulture-based chemical production to maintain a dominant position in the Southern Hemisphere market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Tartaric Products.